Telehealth General Psychiatry Prescribing: What PMHNPs Can Do in North Carolina

If you’re a psychiatrist or psychiatric nurse practitioner considering telehealth, you’ve probably asked: Can I actually prescribe medications—including controlled substances like Adderall or Xanax—through video visits? The short answer in 2026 is yes, in most cases. But the details matter, especially when it comes to controlled substances, state-specific rules, and the differences between what MDs and NPs can do.

Let’s cut through the confusion. This guide walks you through the federal and state regulations governing psychiatric prescribing via telehealth, what you can prescribe remotely, and how the rules differ if you’re a psychiatrist versus a PMHNP.

The Federal Picture: DEA Flexibilities Still in Effect

The biggest change enabling telepsychiatry prescribing came during COVID-19, when the DEA temporarily waived the Ryan Haight Act’s requirement for an in-person exam before prescribing controlled substances. That waiver has been extended through December 31, 2025, meaning psychiatrists can still initiate Schedule II–V medications (stimulants for ADHD, benzodiazepines for anxiety, buprenorphine for opioid use disorder) via telehealth without ever seeing the patient face-to-face.

The reality: You can start a new ADHD patient on Adderall or a new anxiety patient on Xanax over a video visit, as long as you establish a valid patient-provider relationship through real-time audio-visual consultation.

What’s coming: The DEA has proposed permanent rules that may reimpose some in-person requirements (or create special telemedicine registration pathways), but as of early 2026, those aren’t finalized. Expect clarity by late 2025. Until then, the flexibilities remain, and psychiatrists nationwide are leveraging them.

Key federal requirement: You must use a secure, HIPAA-compliant video platform that allows you to conduct an exam meeting the standard of care—basically, the same clinical assessment you’d do in person. Phone-only visits can work for follow-ups in some states (Medicare covers audio-only mental health visits for patients without video access), but initial controlled substance prescriptions generally require video.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

State-by-State Variations: Where You Can Prescribe What

Federal law sets the floor, but state laws add layers. Some states explicitly permit teleprescribing of controlled substances for psychiatric treatment; others have restrictions. Here’s what matters in the six states with the highest psychiatric demand:

California

• MDs: Full prescribing authority via telehealth. A video exam satisfies California’s ‘good faith exam’ requirement. You can prescribe any psychiatric medication, including Schedule II stimulants, after a telehealth evaluation.
• PMHNPs: Depends on experience. New NPs need physician-supervised standardized procedures. By 2026, experienced NPs (3+ years) can obtain ‘104 NP’ certification for full independent practice, including prescribing controlled substances without physician oversight.
• Controlled substances: Allowed via telehealth. California requires checking CURES (the state prescription monitoring program) before prescribing Schedule II–IV drugs.
• Telehealth parity: Private insurers must reimburse telehealth at the same rate as in-person visits.

Bottom line: California is telehealth-friendly for psychiatrists and moving toward NP independence. Just ensure you’re checking CURES and documenting appropriately.

Texas

• MDs: Full independent prescribing via telehealth, with one exception—you cannot prescribe opioids for chronic pain management without an in-person exam. Mental health prescribing (ADHD stimulants, anxiety meds) is explicitly allowed via telemedicine.
• PMHNPs: Heavily restricted. NPs must have a Prescriptive Authority Agreement with a Texas physician for any prescribing. Texas law limits NPs to prescribing Schedule III–V controlled substances in most outpatient settings; Schedule II stimulants require special delegation and are often prescribed by the supervising physician instead.
• Controlled substances: Texas allows psychiatric controlled substance prescribing via telehealth under federal waivers, but NPs face significant barriers. The physician must be available for monthly meetings (first 3 years) then quarterly. One physician can supervise max 7 NPs/PAs.
• Telehealth parity: No state mandate, though many insurers voluntarily cover at parity.

Bottom line: Texas psychiatrists have broad telehealth prescribing freedom. PMHNPs operate more like supervised extenders and often can’t independently manage stimulant therapy—frustrating in a state with 380 mental health shortage areas.

Florida

• MDs: Full prescribing via telehealth. Florida is one of the most permissive states: state law explicitly allows controlled substance prescribing via telehealth for psychiatric disorders (and inpatient/hospice care), while prohibiting it for chronic pain. You can initiate and manage ADHD, anxiety, and other psychiatric medications entirely online.
• PMHNPs: Must practice under a physician’s protocol. Florida grants ‘autonomous’ practice only to primary care NPs—psychiatric NPs are excluded. However, Florida law carves out an exception for ‘psychiatric nurses’ (PMHNPs with 2+ years psych experience): they can prescribe psychotropic controlled substances in collaboration with a psychiatrist (not just any physician). Schedule II prescriptions by NPs are capped at 7 days unless the NP is treating mental illness, in which case that limit doesn’t apply.
• Controlled substances: Fully allowed for psychiatric treatment via telehealth. Florida Statutes §456.47 and §464.012 explicitly authorize this.
• Telehealth parity: No mandate, but broad insurer support due to demand.

Bottom line: Florida is a goldmine for telepsychiatrists—you can prescribe everything remotely. PMHNPs can do a lot if they have a collaborating psychiatrist, but they’re not independent.

New York

• MDs: Full prescribing via telehealth, including controlled substances. New York recently finalized regulations (mid-2025) aligning state rules with federal DEA waivers, so you can prescribe controlled meds via video without an in-person exam while federal flexibilities are active.
• PMHNPs: Reduced practice transitioning to independence. New NPs must work under a collaborative agreement for their first 3,600 hours (about 2 years). After that, they can practice and prescribe independently—no physician oversight required. Experienced NY PMHNPs operate essentially like psychiatrists in terms of prescribing authority.
• Controlled substances: Allowed via telehealth under current DEA rules. New York requires e-prescribing for all controlled substances and checking the state PMP (I-STOP registry) before prescribing Schedule II–IV drugs.
• Telehealth parity: Strong—all insurers must cover telehealth for mental health at parity.

Bottom line: New York is increasingly NP-friendly, making it a good state for both MDs and experienced PMHNPs to practice telehealth. Just keep your prescribing documentation tight and PMP checks current.

Pennsylvania

• MDs: Full independent prescribing via telehealth. No special state restrictions on controlled substance teleprescribing beyond federal law.
• PMHNPs: Must have a collaborative agreement with a physician indefinitely—no pathway to independence yet (legislation pending). The collaborating physician must be willing to delegate controlled substance prescribing, and for Schedule II drugs, NPs are limited to 30-day supplies and must notify the physician within 24 hours. Many PA PMHNPs work for health systems or telehealth companies that provide the collaborator.
• Controlled substances: Allowed via telehealth under DEA waivers. Chart cosigning and periodic meetings required per collaboration agreement.
• Telehealth parity: No comprehensive mandate, though Medicaid and many private plans cover at parity.

Bottom line: Pennsylvania psychiatrists can practice telehealth freely. PMHNPs face administrative burdens—finding a collaborating psychiatrist is often a pain point.

Illinois

• MDs: Full independent prescribing via telehealth.
• PMHNPs: Must complete 4,000 hours of supervised practice + 250 hours of continuing education before applying for Full Practice Authority. Until then, they need a Written Collaborative Agreement with a physician. Once they achieve FPA licensure, they can prescribe independently, including controlled substances (with their own DEA registration).
• Controlled substances: Allowed via telehealth. Illinois NPs without FPA can prescribe Schedule III–V; Schedule II requires physician consultation and is limited to 30 days initially.
• Telehealth parity: Strong—Illinois law mandates private insurers reimburse telehealth at parity through at least 2027 for behavioral health.

Bottom line: Illinois offers a clear path to independence for NPs after a couple years. Psychiatrists operate as usual. The state’s parity law makes telehealth economically viable.

Psychiatrist vs PMHNP: Key Prescribing Differences

Let’s be blunt about the reality:

Psychiatrists (MD/DO):

• Unrestricted prescribing authority in all 50 states
• Can prescribe any Schedule II–V medication independently
• No collaboration, supervision, or chart review requirements
• Can practice telehealth across state lines (with appropriate licenses)
• Medicare/private insurance reimburses at 100% of fee schedule
• Typical Medicare rates: ~$173 for initial eval (90792), ~$95 for 15-min follow-up (99213), ~$136 for 25-min follow-up (99214)

PMHNPs:

• Authority varies dramatically by state (from full independence to heavy restriction)
• In 34 states (as of 2025), can eventually practice independently with full prescribing authority
• In restricted states (TX, FL, PA, etc.), must have physician collaboration agreements—often with chart review requirements, periodic meetings, and limits on controlled substance prescribing
• Medicare reimburses at 85% of physician rates when billed under NP’s NPI
• In some states (like Texas), practically cannot prescribe Schedule II stimulants without physician involvement
• Finding a collaborating psychiatrist can be a significant barrier and expense in restricted states

For telehealth platforms: This means the team structure and supervision model must adapt state by state. A platform operating in Texas needs psychiatrist oversight for NPs prescribing stimulants; the same platform in Oregon can let experienced PMHNPs operate solo.

What This Means for Your Practice

If you’re a psychiatrist:

• You can build a nationwide telehealth practice by obtaining licenses in multiple states (IMLC member states make this easier—Texas, Pennsylvania, and Illinois are members; California, New York, and Florida are not)
• You can prescribe virtually all psychiatric medications via video visits under current federal allowances
• Focus on states with the worst shortages (Texas, Florida) where demand is highest
• Ensure you’re checking state prescription monitoring programs (required in all six priority states before prescribing controlled substances)
• Document the telehealth modality, patient consent, and emergency protocols for compliance

If you’re a PMHNP:

• Research your state’s scope of practice laws carefully—the rules change frequently
• If you’re in a restricted state, factor in the cost and logistics of finding a collaborating physician (fees typically range $1,000–$3,000/year, plus their time requirements)
• If you’re in a state with a path to independence (CA, NY, IL), understand the hour and education requirements and plan your transition
• Consider whether multi-state practice is realistic given varying supervision requirements
• Know that some telehealth platforms provide collaborating physicians as part of their model, which can solve the biggest pain point

For both:

• Stay alert for DEA rule changes expected by end of 2025—the permanent framework may require periodic in-person visits or special registrations
• Telehealth reimbursement parity is here to stay for mental health—this is not a temporary pandemic thing anymore
• The economics work: patient demand is massive, no-show rates are lower via telehealth, and overhead is minimal compared to brick-and-mortar

The Business Case for Telehealth Prescribing

Here’s where things get interesting economically.

Traditional marketing approach:If you’re trying to build a psychiatric practice through DIY marketing (SEO, Google Ads, directory listings), you’re looking at:

• $200–500+ per acquired patient when you factor in ALL costs
• SEO takes 6–12 months of consistent investment before meaningful patient flow
• Google Ads for ‘psychiatrist near me’ or ‘ADHD treatment’ run $15–40+ per click, with conversion rates meaning $200–400+ per booked patient
• Psychology Today, Zocdoc, and other directories charge monthly fees ($30–200/month) PLUS you’re competing with hundreds of other providers on the same page
• No guarantee of patient quality or show rates

Platform approach (like Klarity):Instead of spending thousands monthly on marketing with uncertain ROI, platforms like Klarity use a pay-per-appointment model:

• No upfront marketing spend or monthly subscriptions
• Pre-qualified patients already matched to your specialty and availability
• No wasted ad spend on clicks that don’t convert
• Built-in telehealth infrastructure (no separate platform costs)
• Both insurance and cash-pay patient flow
• You control your schedule—only pay when you see patients

ROI comparison:Let’s say you want to see 20 new patients per month:

• DIY marketing: $3,000–5,000/month in ad spend, SEO, directory fees, VA time to handle leads → many months to ramp up, high risk
• Platform model: Standard listing fee per booked appointment (similar to Zocdoc’s model) → immediate patient flow, guaranteed ROI, zero risk

For most providers—especially those starting out or scaling—removing the patient acquisition risk entirely is the smarter play. You’re guaranteed to only pay when you actually see a patient.

FAQ: Common Questions About Telehealth Prescribing

Can I prescribe stimulants for ADHD via telehealth?Yes, under current federal DEA waivers (through end of 2025) you can initiate and manage stimulant prescriptions entirely via video visits. Some states (like Texas for NPs) have additional restrictions, but psychiatrists generally have full authority.

Do I need an in-person visit before prescribing controlled substances?Not currently, thanks to federal flexibilities. This may change when DEA finalizes permanent rules (expected late 2025), but for now, a video exam satisfies the requirement for most psychiatric controlled substances.

Can I prescribe across state lines?Only if you hold an active license in the state where the patient is located at the time of the visit. The Interstate Medical Licensure Compact (IMLC) can expedite getting licenses in member states.

What about prescribing buprenorphine for opioid use disorder?The DATA 2000 X-waiver requirement was eliminated in 2023, so any DEA-registered practitioner can prescribe buprenorphine without special training. You can initiate buprenorphine via telehealth under current DEA flexibilities.

Are PMHNPs reimbursed the same as psychiatrists?Not quite—Medicare pays NPs at 85% of physician rates when billed under the NP’s NPI. Some states have equal reimbursement laws, and some private payers reimburse at parity, but generally expect slightly lower rates for NP services.

What documentation do I need for telehealth prescribing?Document the same as in-person: thorough psychiatric evaluation, mental status exam, treatment plan, and informed consent. Additionally, note the technology used, patient location, emergency protocols, and that you checked the prescription monitoring database before prescribing controlled substances.

Can I do phone-only visits and prescribe?For follow-ups, sometimes yes—Medicare covers audio-only mental health visits for patients without video access, and some states allow it. But initial controlled substance prescriptions generally require video to meet the standard of care.

What happens if DEA rules change?Stay updated via DEA announcements and professional organizations. Worst case, you might need to see patients in person once initially or annually, but the trend is toward maintaining telehealth access for mental health given the workforce crisis.

Bottom Line: Telehealth Prescribing Is Here to Stay

The regulatory environment for psychiatric telehealth prescribing in 2026 is favorable and stable. Psychiatrists have broad authority to prescribe virtually all medications via video visits, including controlled substances, under current federal allowances and state carve-outs for mental health treatment.

PMHNPs face more variable rules depending on state, but the overall trend is toward expanding their authority—over a dozen states have granted full practice authority since 2020, with more likely to follow.

The business model works: high patient demand, strong reimbursement parity, low overhead, and reduced no-shows via telehealth. The key is understanding your state’s specific rules, maintaining compliance with prescription monitoring programs, and staying alert for federal DEA rule changes expected later this year.

For providers considering telehealth: The patient acquisition challenge is real, but platforms that handle that for you (with pay-per-appointment models) eliminate the biggest risk. Instead of gambling $5,000/month on marketing, you pay only when qualified patients book with you.

Ready to grow your psychiatric practice via telehealth? Join Klarity Health’s provider network to access pre-qualified patients, built-in telehealth infrastructure, and insurance + cash-pay patient flow—without the upfront marketing spend. Learn more about joining Klarity.

References and Sources

1. California Board of Registered Nursing – AB 890 Implementation (rn.ca.gov/practice/ab890.shtml) – Updated Nov 2023
2. Texas Board of Nursing – APRN Practice FAQ (bon.texas.gov/faqpracticeaprn.asp.html) – Revised 2021
3. Florida Statutes Chapter 464 & 456 – Nursing and Telehealth Acts (flsenate.gov/laws/statutes/2024/464.012) – 2024 Statute Compilation
4. JDSupra Law News – ‘New Law Allows Experienced NPs to Practice Without Collaborative Relationship’ (jdsupra.com/legalnews/new-law-allows-experienced-nps-to-8292796) – April 13, 2022
5. Pennsylvania Coalition of Nurse Practitioners – Scope of Practice (pacnp.org/general/custom.asp?page=ScopeofPractice) – Updated 2022

Source:

• https://www.bon.texas.gov/faqpracticeaprn.asp.html#:~:text=certificate%20or%20fetal%20death%20certificate,For%20additional%20information
• https://www.npschools.com/blog/guide-to-np-practice-in-florida#:~:text=match%20at%20L200%20%E2%80%9CUnder%20HB,%E2%80%9D
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.flsenate.gov/laws/statutes/2024/464.012#:~:text=,the%20treatment%20of%20mental%20disorders
• https://www.cchpca.org/texas/#:~:text=including%2C%20but%20not%20limited%20to%2C,Code%2C%20Chapters%20481%20and%20483
• https://www.cchpca.org/texas/#:~:text=,way%20communication
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=As%20of%202025%2C%20the%20distribution,toward%20greater%20autonomy%20for%20NPs
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=,Michigan%20%282025
• https://www.pacnp.org/general/custom.asp?page=ScopeofPractice#:~:text=tests%2C%20and%20deliver%20other%20health,appropriate%20experience%20can%20receive%20a
• https://www.jdsupra.com/legalnews/new-law-allows-experienced-nps-to-8292796/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship